Voss, Martin H <br/><br/>
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2014 
 - 1955-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-2345  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Renal Cell--drug therapy<br/>Exome<br/>Genome, Human<br/>Humans<br/>Indoles--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrroles--administration & dosage<br/>Signal Transduction--genetics<br/>Sunitinib<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Tuberous Sclerosis Complex 1 Protein<br/>Tumor Suppressor Proteins--biosynthesis